Chapter V. Beta-Cell Replacement

Islet Neogenesis: A Possible Pathway for Beta-Cell Replenishment

Susan Bonner-Weir, Lili Guo, Wan-Chun Li, Limor Ouziel-Yahalom, Philippe A. Lysy, Gordon C. Weir, Arun Sharma

Manuscript submitted December 16, 2012; accepted January 21, 2013.

Keywords: diabetes, islet, insulin, pancreatic beta-cell, neogenesis, regeneration, replication

Abstract

Diabetes, particularly type 1 diabetes, results from the lack of pancreatic β-cells. β-cell replenishment can functionally reverse diabetes, but two critical challenges face the field: 1. protection of the new β-cells from autoimmunity and allorejection, and 2. development of β-cells that are readily available and reliably functional. This chapter will examine the potential of endogenous replenishment of pancreatic β-cells as a possible therapeutic tool if autoimmunity could be blunted. Two pathways for endogenous replenishment exist in the pancreas: replication and neogenesis, defined as the formation of new islet cells from pancreatic progenitor/stem cells. These pathways of β-cell expansion are not mutually exclusive and both occur in embryonic development, in postnatal growth, and in response to some injuries. Since the β-cell population is dramatically reduced in the pancreas of type 1 diabetes patients, with only a small fraction of the β-cells surviving years after onset, replication of preexisting β-cells would not be a reasonable start for replenishment. However, induction of neogenesis could provide a starting population that could be further expanded by replication. It is widely accepted that neogenesis occurs in the initial embryonic formation of the endocrine pancreas, but its occurrence anytime after birth has become controversial because of discordant data from lineage tracing experiments. However, the concept was built upon many observations from different models and species over many years. Herein, we discuss the role of neogenesis in normal growth and regeneration, as learned from rodent models, followed by an analysis of what has been found in humans.

Fulltext: HTML , PDF (178KB)

This article has been cited by other articles:

	Pancreatic beta-cell regeneration: Facultative or dedicated progenitors? Afelik S, Rovira M Mol Cell Endocrinol 2017. 445:85-94
	Bariatric surgery influences beta-cell turnover in non obese rats Camacho-Ramirez A, Blandino-Rosano M, Segundo-Iglesias MC, Lechuga-Sancho AM, Aguilar-Diosdado M, Perez-Arana GM, Prada-Oliveira JA Histol Histopathol 2017. In press
	Stress-induced adaptive islet cell identity changes Cigliola V, Thorel F, Chera S, Herrera PL Diabetes Obes Metab 2016. 18(Suppl 1):87-96
	New Insights into Diabetes Cell Therapy Lysy PA, Corritore E, Sokal EM Curr Diab Rep 2016. 16(5):38
	Unique Aspects of Cryptochrome in Chronobiology and Metabolism, Pancreatic Beta-Cell Dysfunction, and Regeneration: Research into Cysteine414-Alanine Mutant CRY1 Okano S J Diabetes Res 2016. 2016:3459246
	Beta-cell replacement sources for type 1 diabetes: a focus on pancreatic ductal cells Corritore E, Lee YS, Sokal EM, Lysy PA Ther Adv Endocrinol Metab 2016. 7(4):182-199
	Beta-Cell dedifferentiation, reduced duct cell plasticity, and impaired β-cell mass regeneration in middle-aged rats Tellez N, Vilaseca M, Marti Y, Pla A, Montanya E Am J Physiol Endocrinol Metab 2016. 311(3):E554-E563
	The Human Endocrine Pancreas: New Insights on Replacement and Regeneration Dominguez-Bendala J, Lanzoni G, Klein D, Alvarez-Cubela S, Pastori RL Trends Endocrinol Metab 2016. 27(3):153-162
	The Rise and the Fall of Betatrophin/ANGPTL8 as an Inducer of beta-Cell Proliferation Abu-Farha M, Al Madhoun A, Abubaker J J Diabetes Res 2016. 2016:4860595
	Cellular therapy of diabetes: focus on the latest developments Lysy PA Med Sci (Paris) 2016. 32(4):401-407
	Antidiabetic and Antioxidant Impacts of Desert Date (Balanites aegyptiaca) and Parsley (Petroselinum sativum) Aqueous Extracts: Lessons from Experimental Rats Abou Khalil NS, Abou-Elhamd AS, Wasfy SI, El Mileegy IM, Hamed MY, Ageely HM J Diabetes Res 2016. 2016:8408326
	Beta-Cell Identity in Type 2 Diabetes: Lost or Found? Butler AE, Dhawan S Diabetes 2015. 64(8):2698-2700
	The double trouble of metabolic diseases: the diabetes-cancer link Tudzarova S, Osman MA Mol Biol Cell 2015. 26(18):3129-3139
	Development, growth and maintenance of β-cell mass: models are also part of the story Khadra A, Schnell S Mol Aspects Med 2015. 42:78-90
	Direct Reprogramming for Pancreatic Beta-Cells Using Key Developmental Genes Cavelti-Weder C, Li W, Zumsteg A, Stemann M, Yamada T, Bonner-Weir S, Weir G, Zhou Q Curr Pathobiol Rep 2015. 3(1):57-65
	Beta-cell induction in vivo in severely diabetic male mice by changing the circulating levels and pattern of the ratios of estradiol to androgens Inada A, Inada O, Fujii NL, Fujishima K, Inai T, Fujii H, Sueishi K, Kurachi K Endocrinology 2014. 155(10):3829-3842
	Maturation of stem cell-derived beta-cells guided by the expression of urocortin 3 van der Meulen T, Huising MO Rev Diabet Stud 2014. 11(1):115-132
	In vitro differentiation and expansion of human pluripotent stem cell-derived pancreatic progenitors Chmielowiec J, Borowiak M Rev Diabet Stud 2014. 11(1):19-34